Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY) Hits New 52-Week High – Here’s What Happened

Shares of Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY) hit a new 52-week high on Thursday . The stock traded as high as $10.2750 and last traded at $10.04, with a volume of 5791 shares. The stock had previously closed at $9.94.

Shionogi & Co., Ltd. Unsponsored ADR Stock Performance

The company has a debt-to-equity ratio of 0.01, a quick ratio of 5.74 and a current ratio of 6.44. The business’s 50-day moving average is $8.95 and its 200-day moving average is $8.70. The company has a market capitalization of $17.27 billion, a PE ratio of 15.86, a PEG ratio of 2.08 and a beta of 0.19.

Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY) last announced its quarterly earnings data on Monday, October 27th. The company reported $0.18 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.16 by $0.02. Shionogi & Co., Ltd. Unsponsored ADR had a return on equity of 11.90% and a net margin of 39.53%.The business had revenue of $740.85 million during the quarter, compared to analysts’ expectations of $742.35 million. On average, research analysts anticipate that Shionogi & Co., Ltd. Unsponsored ADR will post 0.66 earnings per share for the current year.

Shionogi & Co., Ltd. Unsponsored ADR Company Profile

Shionogi & Co, Ltd. is a Japan-based pharmaceutical company that conducts research, development, manufacturing and marketing of prescription drugs and vaccines. Established in the late 19th century, the company has expanded its focus beyond domestic markets to become a global player in pharmaceuticals, with particular expertise in anti-infectives, pain management, cardiovascular and central nervous system disorders.

The company’s product portfolio spans both established and innovative therapies.